title: Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db/db mice.
abstract: Obesity and a nondipping circadian blood pressure (BP) pattern are associated with diastolic dysfunction. Ectopic lipid accumulation is increasingly recognized as an important metabolic abnormality contributing to diastolic dysfunction. However, little is known about the contribution of different lipids and the composition of lipid analytes to diastolic dysfunction. We have performed functional and structural studies and analyzed cardiac lipid profile at two time points during progression to diastolic dysfunction in a genetic model of obesity. Serial cardiac magnetic resonance imaging and telemetric measures of BP between 12 and 15 wk of age in obese male db/db mice indicated a nondipping circadian BP pattern and normal diastolic function at 12 wk that progressed to a deteriorating nondipping pattern and onset of diastolic dysfunction at 15 wk of age. Lipidomic analysis demonstrated elevated fatty acids and ceramides in db/db at 12 wk, but their levels were decreased at 15 wk, and this was accompanied by persistent mitochondrial ultrastructural abnormalities in concert with evidence of increased fatty acid oxidation and enhanced production of reactive oxygen species. Triacylglyceride and diacylglyceride levels were elevated at both 12 and 15 wk, but their composition changed to consist of more saturated and less unsaturated fatty acyl at 15 wk. An increase in the lipid droplets was apparent at both time points, and this was associated with increases in phosphatidycholine. In conclusion, a distinct pattern of myocardial lipid remodeling, accompanied by oxidative stress, is associated with the onset of diastolic dysfunction in obese, insulin-resistant db/db mice.
authors.affiliation: Departments of Internal Medicine, University of Missouri-Columbia School of Medicine, One Hospital Drive, Columbia, MO 65212, USA. demarcov@missouri.edu
authors.forename: Vincent G
authors.initials: VG
authors.lastname: Demarco
authors.forename: David A
authors.initials: DA
authors.lastname: Ford
authors.forename: Erik J
authors.initials: EJ
authors.lastname: Henriksen
authors.forename: Annayya R
authors.initials: AR
authors.lastname: Aroor
authors.forename: Megan S
authors.initials: MS
authors.lastname: Johnson
authors.forename: Javad
authors.initials: J
authors.lastname: Habibi
authors.forename: Lixin
authors.initials: L
authors.lastname: Ma
authors.forename: Ming
authors.initials: M
authors.lastname: Yang
authors.forename: Carolyn J
authors.initials: CJ
authors.lastname: Albert
authors.forename: John W
authors.initials: JW
authors.lastname: Lally
authors.forename: Caleb A
authors.initials: CA
authors.lastname: Ford
authors.forename: Mujalin
authors.initials: M
authors.lastname: Prasannarong
authors.forename: Melvin R
authors.initials: MR
authors.lastname: Hayden
authors.forename: Adam T
authors.initials: AT
authors.lastname: Whaley-Connell
authors.forename: James R
authors.initials: JR
authors.lastname: Sowers
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000502:physiology*; D002518:Ceramides / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism; D008297:Male; D051379:Mice; D009206:Myocardium / Q000378:metabolism*; D009765:Obesity / Q000378:metabolism* / Q000503:physiopathology*; D018384:Oxidative Stress; D010713:Phosphatidylcholines / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D002518:Ceramides; D005227:Fatty Acids; D010713:Phosphatidylcholines; D017382:Reactive Oxygen Species